Mahmood Jeddi-Tehrani Selected Research

Phosphotransferases (Kinase)

4/2013	Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies.
1/2007	Overexpression of orphan receptor tyrosine kinase Ror1 as a putative tumor-associated antigen in Iranian patients with acute lymphoblastic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mahmood Jeddi-Tehrani Research Topics

Disease

55	Neoplasms (Cancer) 01/2024 - 01/2007
17	Breast Neoplasms (Breast Cancer) 09/2023 - 04/2009
17	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2015 - 02/2003
12	Infections 04/2024 - 05/2014
9	Whooping Cough (Pertussis) 04/2024 - 06/2007
8	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 06/2005
8	Tetanus 10/2021 - 06/2007
7	Spontaneous Abortion (Miscarriage) 07/2017 - 04/2006
6	Hepatitis B 09/2022 - 09/2013
6	Carcinoma (Carcinomatosis) 12/2015 - 07/2009
5	Testicular Neoplasms (Testicular Cancer) 07/2023 - 05/2014
5	Habitual Abortion (Recurrent Miscarriage) 10/2015 - 08/2010
4	Leukemia 01/2014 - 02/2003
4	Hematologic Neoplasms (Hematological Malignancy) 04/2013 - 01/2010
3	Carcinogenesis 01/2024 - 01/2014
3	COVID-19 01/2022 - 01/2021
3	Colorectal Neoplasms (Colorectal Cancer) 05/2019 - 01/2004
3	Infertility (Sterility) 01/2019 - 04/2006
3	Ovarian Neoplasms (Ovarian Cancer) 08/2018 - 12/2009
3	Endometriosis 09/2014 - 06/2008
3	Diphtheria 06/2013 - 06/2007
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2011 - 06/2005
2	Lung Neoplasms (Lung Cancer) 12/2022 - 12/2022
2	Spasm (Spasms) 10/2021 - 02/2020
2	Prostatic Neoplasms (Prostate Cancer) 07/2019 - 01/2015
2	Obesity 02/2016 - 10/2012
2	Choroidal Neovascularization 10/2015 - 11/2013
2	Brucellosis (Malta Fever) 11/2014 - 11/2014
2	Communicable Diseases (Infectious Diseases) 01/2014 - 05/2009
2	Thrombophilia 09/2010 - 04/2006
2	Pathologic Processes 08/2010 - 01/2007
1	Lymphatic Metastasis 01/2023

Drug/Important Bio-Agent (IBA)

25	AntigensIBA 07/2023 - 02/2003
24	Monoclonal AntibodiesIBA 08/2023 - 04/2009
18	Proteins (Proteins, Gene)FDA Link 01/2024 - 06/2005
16	AntibodiesIBA 12/2022 - 06/2007
15	VaccinesIBA 04/2024 - 02/2003
9	Trastuzumab (Herceptin)FDA Link 01/2022 - 07/2013
9	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2018 - 01/2007
8	EpitopesIBA 06/2023 - 02/2003
6	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2015
5	Tumor Biomarkers (Tumor Markers)IBA 09/2023 - 07/2009
5	Immunoglobulins (Immunoglobulin)IBA 09/2022 - 10/2016
5	CytokinesIBA 01/2019 - 06/2008
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2017 - 09/2013
4	human ERBB2 proteinIBA 08/2023 - 01/2016
4	EnzymesIBA 12/2022 - 01/2007
4	Peptides (Polypeptides)IBA 01/2022 - 01/2014
3	Hemagglutinins (Hemagglutinin)IBA 04/2024 - 02/2015
3	ImmunosorbentsIBA 12/2022 - 01/2020
3	hepatitis B hyperimmune globulinIBA 09/2022 - 10/2016
3	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 09/2010
3	LigandsIBA 10/2021 - 07/2014
3	pertuzumabIBA 01/2021 - 01/2018
3	tetanospasmin (tentoxilysin)IBA 02/2020 - 01/2014
3	Prostate-Specific Antigen (Semenogelase)IBA 01/2019 - 12/2014
3	sortilinIBA 12/2015 - 07/2009
3	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 10/2015 - 04/2006
3	FibromodulinIBA 08/2013 - 06/2005
3	Messenger RNA (mRNA)IBA 01/2013 - 02/2008
3	Pertussis VaccineIBA 01/2013 - 06/2007
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 08/2008 - 02/2003
2	AutoantibodiesIBA 01/2023 - 12/2022
2	ProteomeIBA 01/2023 - 01/2023
2	Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate)IBA 01/2023 - 01/2020
2	NucleolinIBA 12/2022 - 12/2022
2	Receptor Tyrosine Kinase-like Orphan ReceptorsIBA 11/2022 - 01/2018
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022 - 09/2008
2	Immunoglobulin G (IgG)IBA 12/2021 - 01/2021
2	NeurotoxinsIBA 10/2021 - 03/2020
2	hersintuzumabIBA 01/2021 - 01/2018
2	Carcinoembryonic AntigenIBA 05/2019 - 01/2004
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 05/2019 - 01/2004
2	Docetaxel (Taxotere)FDA Link 11/2018 - 10/2017
2	Fluorescein-5-isothiocyanate (FITC)IBA 08/2018 - 03/2013
2	Insulin (Novolin)FDA Link 02/2016 - 04/2015
2	Virulence Factors (Pathogenicity Factors)IBA 02/2016 - 02/2015
2	Bevacizumab (Avastin)FDA Link 10/2015 - 11/2013
2	Retinaldehyde (Retinal)IBA 10/2015 - 11/2013
2	ResveratrolIBA 10/2015 - 10/2013
2	Cholecalciferol (Vitamin D3)FDA Link 05/2015 - 09/2011
2	Subunit VaccinesIBA 11/2014 - 11/2014
2	Small Interfering RNA (siRNA)IBA 07/2014 - 01/2013
2	Plasminogen Activator Inhibitor 1IBA 01/2014 - 11/2012
2	IronIBA 10/2013 - 04/2009
2	Phosphotransferases (Kinase)IBA 04/2013 - 01/2007
2	tyrosine receptor (receptor, tyrosine)IBA 04/2013 - 01/2007
2	Factor XIII (Coagulation Factor XIII)IBA 04/2012 - 09/2010
2	factor V LeidenIBA 04/2012 - 04/2006
2	HesperidinIBA 02/2012 - 01/2011
2	FenretinideIBA 10/2011 - 01/2010
2	hydroxide ionIBA 10/2011 - 09/2011
2	Diphtheria-Tetanus-Pertussis Vaccine (DPT Vaccine)IBA 06/2009 - 06/2007
1	Hepatitis B e AntigensIBA 07/2023
1	Tetanus ToxinIBA 06/2023
1	N 30IBA 01/2023
1	pertactin FDA Link 01/2023

Therapy/Procedure

16	Immunotherapy 12/2022 - 01/2007
14	Therapeutics 01/2022 - 09/2008
2	Quantum Dots (Quantum Dot) 08/2018 - 03/2013